Cowen and Company Reaffirms Outperform Rating for Array BioPharma Inc. (ARRY)
Cowen and Company reiterated their outperform rating on shares of Array BioPharma Inc. (NASDAQ:ARRY) in a report released on Monday, September 11th. The brokerage currently has a $15.00 target price on the biopharmaceutical company’s stock, up from t
EXEL to acquire ARRY ? Just posted on Yahoo front page. Michael Morrissey, Exelixis' CEO, recently stated that the company plans to add oncology assets either through partnering with another biotech or making an acquisition. That's smart. There's a good chance that Cabometyx will win regulatory approval as a first-line treatment for kidney cancer. That would increase Exelixis' revenue and cash flow significantly, allowing the company to reinvest to fuel more growth. Repeat this process a few times, and Exelixis' market cap could multiply.
Atlantic I bet your also a Pittsburg fan , hiding in the locker room during the American Anthem, losers Ill never ever watch their games again.
I'm thinking there might be a leak that EXEL buy ARRY in a stock swap deal 1 EXEL share for 1 ARRY share, EXEL has dropped over $5.00 in the last 3 trading days from 28.50s to 23.25 as of now. I expect something to be announced as I think there has been a leak. ONLY my opinion Atlantic #$%$
$12 tomorrow. Eventually I will be right. Good things are coming!
Where's no moneys posts? Deleted again, why? Amazing how little you know, buy high sell low is your game But you have no game, sell mutual funds and cds please
I have owned this stock for over 7 years, and have followed it diligently. This company is the real deal. I am not only glad for their success for personal monetary reasons, but also for the benefit this company and their research will bring to cancer patients. ARRY deserves the respect they are finally getting!!! These nice new price targets reflect the long overdue belief in this company and its pipeline.
ARRY 5 PHASE3. I do not understand that Mkt Cap is 2B. ALNY/10B. JUNO/5B.
ARRY is opportunity of life time. Rare bird in the jungle of the market.
Ok folks, we are closing on breakout territory. We need to slice above 11.95. Above that there is only a single strength resistance at 13.25 before the 52 week high at 13.40 which is also single strength. Let's hope for a close above 11.95 by Thursday and confirmation the following day. If so we will be in breakout and momentum will be strong for continued upward movement.
Cramer's lightning round: I like Altria Group, but it's n...
Jim Cramer flies through his take on callers' favorite stocks, including one tobacco giant.
Another BS prediction from yen om or dead money, predicted array down 2-3% everyday Said ah drop on bad news, only good news is he or she is hopefully getting fired from there minimum wage job pumping HOT AIR
This is a strong close, strong fight during the day and bouncing back like a king!!! GO ARRY, LONGS!!!
It's pretty impressive how Array did the public offering with the stock going up from the offering price.
If you have a Bloomberg, check it. You will see the Wells upgrade. Yes they really upgraded! It is not a rumor. I do not subscribe to rumors.
Check out crazy Cramer He likes array Great portfolio!!!!
Thanks cramer, we feel good too.
$25 by December.
Last reported short interest: 8/31/2017 ... 23,808,509 .. built-in buyers..